Independent Director · Larimar Therapeutics, Inc. (LRMR)

Frank Thomas director compensation at Larimar Therapeutics: $82.4K

Fiscal year 2025 director compensation for Frank Thomas at Larimar Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 20, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Frank Thomas’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Frank Thomas and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Larimar Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Larimar Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$55,000—$27,400—$82,400
FY2024$55,000$0$102,991$0$157,991
FY2023$53,750—$32,456—$86,206
FY2021$50,000—$61,317—$111,317

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Larimar Therapeutics, Inc. DEF 14A filed April 20, 2026, accession 0001193125-26-163942, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Larimar Therapeutics, Inc. filed document, accession 0001193125-26-163942. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.

Get the Larimar Therapeutics Board Governance Report

$82,400 Frank Thomas, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 20, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Larimar Therapeutics pays directors a $35,000 cash retainer.

The rest of the Larimar Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Carole S. Ben-Maimon, M.DDirector—
Jeffrey W. Sherman, M.D., FACPIndependent Director$66,150
Jonathan LeffIndependent Director$74,900
Joseph TruittChair of the Board$109,900
Thomas E. HamiltonIndependent Director$73,650

The full Larimar Therapeutics compensation record

free company brief

This page is one director within Larimar Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order LRMR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report